Loretta TIOIELA

Next Sequence

#TechBio is changing the world and the world needs to know more about it and the most disruptive companies who want to enable humanity to face up to its next challenges as a species, from fighting genetically transmitted diseases and pandemics to preventing ageing and climate change. In this podcast, we are featuring founders, investors, university professor or tech advisers sharing with us their unique view on the challenges and opportunities behind the Bioeconomy. This podcast is produced by Next Sequence, a venture capital fund focused on supporting globally the #TechBio ecosystem, from fou...

No dejes de visitar la web del podcast y apoyar a su creador: next-sequence.simplecast.com

Autor

Loretta TIOIELA

Categoría

Business

Último episodio

26 de jul. de 2024

¿Dónde escuchar?

Podcasts en la app Replaio Radio Muy pronto

Los podcasts llegarán muy pronto a la app. Instálala ahora y sé el primero en descubrir una forma totalmente nueva de vivir los podcasts

Descárgala en Google Play Instálala gratis Android casi 10 M de descargas · valoración de 4,8 iOS muy pronto

Episodios

TechBio Founders #32: Cleaning the world out of polyethylene plastics by turning nature's enzymes into powerful plastic degradation engines with Eleonore Eisath, Founder at Beworm 26.07.2024

Beworm is a biotechnological start-up facing the challenge of plastic pollution. Our goal is to develop a biotic recycling process that decomposes polyethylene, a commonly used material, into its building blocks. With the help of selected microorganisms and enzymes, the long hydrocarbon chain of polymers can be split up into shorter fragments, which can be reused as raw materials. This will transf...

TechBio Founders #31: Decoupling energy from fuels and emissions by building a super-star on earth with Francesco Volpe and Martin Kupp, CEO and CSO at Renaissance Fusion 21.06.2024

Renaissance Fusion is a fusion energy company on a mission to decouple energy from fuels and emissions by building stellarators, the most efficient, steady, and stable fusion reactors on earth.

TechBio Investors#5-Xavier Mesnier & Perman Jorayev, VC at Verve Ventures 10.04.2024

Verve Ventures is a network and technology-driven venture capital firm headquartered in Switzerland. Founded in 2010, Verve Ventures has grown to more than 45 team members and has become one of the most active venture investors in Europe with over 140 technology and science-driven startups in its portfolio.

TechBio Founders #30: Developing drug pipelines for life extension and age-related disorders with Ivan De Weber, CEO at Cortex Discovery 20.03.2024

Cortex Discovery’s in silico drug discovery platform is based on its leading-edge AI technology which can predict molecule properties in all therapeutic fields. The accuracy of its predictions has been validated in the lab, and rivals that of experiments.

TechBio Investors#4- Sonal Pai, VC at First Spark Ventures 13.03.2024

First Spark Ventures is a Deep Tech venture capital fund investing in breakthrough technologies that make the world healthier, safer, and more productive. First Spark Ventures invests in startups that have fundamental technological insights. We look for stellar teams,large accessible markets, and massive sustainable differentiation.

TechBio Ecosystem & Industry Partners #1-Max Dunhill, ISV Director at Oracle Cloud 27.12.2023

Oracle partners with leading independent software vendors (ISVs) that provide complementary application and technology solutions. Oracle program for ISVs offers a wealth of best practices, lessons learned, and results to share that have transformed—and continue to transform— cloud business. It encompasses Oracle experience migrating more than 60 SaaS-based applications to Oracle Cloud Infrastructu...

TechBio Founders #29: Giving you back better insights on your research data through bioinformatic data mining using natural language without hallucinations and knowledge graph with Christopher LI, CEO at BioBox Analytics 13.12.2023

BioBox is a software company developing a hybrid Knowledge Graph and LLM system to create a new way for scientists to converse with data, without hallucinations. Fast moving teams in biotech are deploying the BioBox platform to hit R&D milestones in target identification and validation up to 5x faster.

TechBio Investors#3- James Bennett , VC at Earlybird Venture Capital 06.12.2023

Earlybird Venture Capital focuses on European technology companies. Founded in 1997, Earlybird identifies and backs exceptional early-stage companies on a pan-European basis and supports them through their growth and development phases – providing financial resources, strategic support, and access to an international network & capital markets. With EUR 2 billion under management across all fund st...

TechBio Founders #28: Improving and saving lives by producing high quality human tissue organoids in earth low orbit and space with Raphael Roettgen , CEO at Prometheus Life Technologies 29.11.2023

Prometheus Life Technologies is a space biology company out of the University of Zurich, specialized in producing organoids in microgravity. Our team is among the world’s most foremost experts in gravitational biology, and has already successfully flown two missions to the International Space Station to grow human tissue organoids, but we are just getting started on our journey to provide health f...

TechBio Founders #27: Re-imagining therapeutics within the timeframe of weeks and not years through AI-based design and a high-throughput drug discovery of mini proteins with Chris BAHL, CSO at AI Proteins 22.11.2023

AI Proteins is a biotech company on a mission to re-imagine protein therapeutics with a novel approach for designing entirely new proteins. Using AI-based design and a high-throughput drug discovery platform, AI Proteins creates de novo proteins optimized for specific therapeutic applications. The AI Proteins platform enables the development of inexpensive, durable, highly specific proteins that h...

TechBio Venture Associate Insights #2-Neuroscience-Sofia Syntaka 17.11.2023

Finishing her PhD in Advanced Therapies and Regenerative Medecine at King's College in UK right now, Sofia is on a mission to support visionaries and companies that develop disruptive solutions for humanity's most pressing challenges, from solving disease to sustainable longevity and environmental preservation. Artificial intelligence and synthetic biology are rapidly evolving, and the impact is t...

TechBio Founders #26: Developing resilient and autonomous supply chains for research and diagnostics with Jenny Molloy, CEO at Beneficial Bio 08.11.2023

Beneficial Bio is a network of social enterprises run by biologists which aims to change the status quo for access to biological tools from scarcity to abundance, accelerating research, innovation and education for the bioeconomy. Beneficial Bio’s short term impact is accelerating and scaling local research. Our long term impact is increasing the agency of more people to shape biotechnology, parti...

TechBio Founders #25: Harnessing evolution to overcome treatment-resistant cancer with Nicholas Goldner, CEO at ResistanceBio 01.11.2023

Helping patients fight treatment-resistant cancer. resistanceBio can discover and overcome clinical treatment resistance pre-clinically.

TechBio Founders #24: Using AI and multi-omics to predict the efficacy of immunotherapies with Vadim Nazarov, CEO at ImmunoMind 25.10.2023

ImmunoMind is a UC Berkeley SkyDeck alumnus company. ImmunoMind helps biotech companies understand crucial drug-human interactions, and transform the biodata chaos into more effective immunotherapies.

TechBio Venture Associate Insights #1-Food & Agriculture-Alexandre MOREL 17.10.2023

After earning his Ph. D. in Biomaterials & Bioengineering from ETH Zurich, Alexandre played a pivotal role in establishing Switzerland's first cultivated meat production line, leading the development of innovative bioreactor designs, bioprocessing techniques, and bio-based materials for cultivating stem cells, muscle, and fat tissues. Currently, Alexandre is actively involved with Next Sequence as...

TechBio Founders #23: Delivering sustainable biomanufacturing with AI-driven microorganism strain optimization with Rachel SHAW, CEO at Eden Bio 08.09.2023

Eden Bio uses machine learning to improve protein yield, saving companies time and money, and helping them get their proteins to market faster.

TechBio Founders #22: Empowering our digital native world and its digital data exponential growth by ushering in the era of DNA data storage with Erfane ARWANI, CEO Biomemory 12.07.2023

Biomemory creates DNA Drives for large corporates and administrations. We organize and store data on biocompatible DNA molecules.

TechBio Founders #21: Answering to today's food production problems by harnessing the power of the marine microbiome with Natalija Stepurko and Federica Pesce, CEO & COO at Bravely Cultured 07.07.2023

At BravelyCultured we are redesigning precision fermentation in order to optimise it for sustainable food production. We take inspiration (as well as microorganisms, seawater and seaweed!) from the ocean to produce animal-free animal proteins in an economically viable way and at scale.

TechBio Founders #20: Regenerating the biodiversity that underpins our food systems by integrating agricultural and biodiversity data across suppliers monitoring through remote sensing and AI with Marianna Herold, CEO NatureBound 16.06.2023

NatureBound is on a mission to regenerate the biodiversity that underpins our food systems. Combining the latest technology in remote sensing and AI with an open ecosystem of monitoring providers, our ML models leverage scalable biodiversity monitoring to predict agricultural outcomes. Integrating agricultural and biodiversity data across monitoring suppliers into our platform enables a swifter an...

TechBio Founders #19: Replacing harmful petrochemicals and reinventing the basic materials we use every day through decentralized and scalable algae biomanufacturing with Elliot Roth, CEO Spira Inc. 31.05.2023

Spira creates carbon negative materials from genetically engineered algae grown by a global network of farming partners to produce ingredients for food, cosmetic and textile companies.

TechBio Founders #18: Fast forwarding the biorevolution in therapeutics modalities by bringing the best cost/performance ratio for generating ultra-high resolution, ultra-high throughput data with Swamy Vijayan, CEO Zafrens 24.05.2023

Zafrens exists at the confluence of engineering, biology, chemistry and informatics to study cells as comprehensively as possible. We map the molecular states of millions of cells at a time to their individual functional manifestations. In doing so we begin to understand the regulatory layers of the cell (how molecular state is converted to function), which, so far has remained challenging to stud...

TechBio Investors#2-Alex Felman, General Partner at Felman Family Office 17.05.2023

Alex Felman is a veteran of the family office community for almost a decade; working as managing director with his own family office, Felman Family Office, on the ground with local families in Brazil, China, Denmark and South Korea and remotely with other family offices around the globe. He uses his expertise in Molecular Toxicology andBio-entrepreneurship(B.A from University of California -Berkel...

TechBio Founders #17: Powering precision medicine in oncology, immunology, infectious diseases, and drug development through single-cell multiomics sequencing technologies with Nan Fang, CEO Singleron Biotechnologies 10.05.2023

Singleron Biotechnologies is an innovative molecular diagnostic company dedicated to applying groundbreaking high-throughput single cell analyses to clinical research, diagnostics and drug development. 500+ single-cell sequencing experts around the world are working together to translate advanced and proprietary multi-omics single-cell technologies into products that can be easily deployed in any...

TechBio Founders #16: Accelerating drug discovery with fully automated robotic experiment execution and digital data capture with Martin-Immanuel Bittner, CEO Arctoris 05.05.2023

Arctoris is a tech-enabled drug discovery company headquartered in Oxford and Boston. Arctoris combines its unique automation platform, Ulysses, with advanced computational approaches and a world-class team of seasoned drug hunters to guide and rapidly progress its wholly owned and partnered drug discovery programs in oncology and neurology.

TechBio Founders #15: Growing the regenerative materials economy with Elizabeth CORBIN, CEO Materiom 26.04.2023

With open data and AI, Materiom empowers scientists, material developers, and brands to accelerate R&D and drive massive market entry. Materiom platform gathers the world of regenerative material solutions to optimize and match them to real-world needs.

Escucha el podcast Next Sequence en Replaio

Radio y podcasts en una sola app - gratis y sin registro. Instálala hoy y no te pierdas el estreno

Descárgala en Google Play

Replaio no es editor de podcasts; los nombres de los programas, las portadas y el audio pertenecen a sus autores y se distribuyen a través de canales RSS públicos